These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 9169884)

  • 1. Blinding of clinical trials with concurrent economic analysis.
    Johnson K
    JAMA; 1997 Jun; 277(21):1677. PubMed ID: 9169884
    [No Abstract]   [Full Text] [Related]  

  • 2. A generic minimization random allocation and blinding system on web.
    Cai H; Xia J; Xu D; Gao D; Yan Y
    J Biomed Inform; 2006 Dec; 39(6):706-19. PubMed ID: 16616696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical trials.
    Ellenberg JH
    Neurol Clin; 1990 Feb; 8(1):15-30. PubMed ID: 2181263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The performance of prospective controlled randomized clinical studies].
    Probst M; Fabian W
    Fortschr Med; 1980 Jan; 98(1):1-2, 14. PubMed ID: 6768660
    [No Abstract]   [Full Text] [Related]  

  • 5. Blinding in clinical trials: a practical approach.
    Bang H; Park JJ
    J Altern Complement Med; 2013 Apr; 19(4):367-9. PubMed ID: 23140113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The blind leading the blind: use and misuse of blinding in randomized controlled trials.
    Miller LE; Stewart ME
    Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment research at the crossroads: the scientific interface of clinical trials and effectiveness research.
    Wells KB
    Am J Psychiatry; 1999 Jan; 156(1):5-10. PubMed ID: 9892291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Controlled trials: allocation concealment, random allocation, and blinding.
    Sedgwick P
    BMJ; 2015 May; 350():h2633. PubMed ID: 25979365
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: "Randomized vs. historical clinical trials: are the benefits worth the cost?".
    Am J Epidemiol; 1986 Aug; 124(2):338-41. PubMed ID: 3088985
    [No Abstract]   [Full Text] [Related]  

  • 11. Behavioral impact and cost analysis of a worksite self-help smoking cessation program.
    Windsor RA; Lowe JB
    Prog Clin Biol Res; 1989; 293():231-42. PubMed ID: 2498905
    [No Abstract]   [Full Text] [Related]  

  • 12. Are clinical trials a cost-effective investment?
    Detsky AS
    JAMA; 1989 Oct; 262(13):1795-800. PubMed ID: 2506366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing allocation concealment and blinding in randomized controlled trials: why bother?
    Schulz KF
    ACP J Club; 2000; 132(2):A11-2. PubMed ID: 10750446
    [No Abstract]   [Full Text] [Related]  

  • 14. Issues in therapeutic apheresis.
    Berkman E
    N Engl J Med; 1982 Jun; 306(23):1418-20. PubMed ID: 6804867
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plaster of paris compared with Hexcelite. A prospective, randomized, cost-benefit analysis of below-the-knee casts].
    Nordkild P; Jørgensen U
    Ugeskr Laeger; 1986 Jun; 148(25):1533-5. PubMed ID: 3092420
    [No Abstract]   [Full Text] [Related]  

  • 16. [Roaming through methodology. XXIII. The need for randomization and blinding in therapeutic investigations].
    Knipschild PG
    Ned Tijdschr Geneeskd; 2000 Sep; 144(38):1826-8. PubMed ID: 11020835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blinding in randomized clinical trials: imposed impartiality.
    Hróbjartsson A; Boutron I
    Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blinding in randomised trials: hiding who got what.
    Schulz KF; Grimes DA
    Lancet; 2002 Feb; 359(9307):696-700. PubMed ID: 11879884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benefit-cost analysis of antimicrobial prophylaxis in abdominal and vaginal hysterectomy.
    Shapiro M; Schoenbaum SC; Tager IB; Muñoz A; Polk BF
    JAMA; 1983 Mar; 249(10):1290-4. PubMed ID: 6402612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistics notes: blinding in clinical trials and other studies.
    Day SJ; Altman DG
    BMJ; 2000 Aug 19-26; 321(7259):504. PubMed ID: 10948038
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.